Can PDL-1 levels predict response to triple regimen (carboplatin + pembrolizumab+ pemetrexed) in treatment for metastatic non-small cell lung cancer – a real world outcome study. (June 2021)

Record Type:: Journal Article
Title:: Can PDL-1 levels predict response to triple regimen (carboplatin + pembrolizumab+ pemetrexed) in treatment for metastatic non-small cell lung cancer – a real world outcome study. (June 2021)
Main Title:: Can PDL-1 levels predict response to triple regimen (carboplatin + pembrolizumab+ pemetrexed) in treatment for metastatic non-small cell lung cancer – a real world outcome study
Authors:: Saxena, Aaruni
Karim, Syed
Shafiq, Tahir
Umar, Sumbal
Ho, Michael
Khan, Sarah
Abstract:
Is Part Of:: Lung cancer. Volume 156(2021)Supplement 1
Journal:: Lung cancer
Issue:: Volume 156(2021)Supplement 1
Issue Display:: Volume 156, Issue 1 (2021)
Year:: 2021
Volume:: 156
Issue:: 1
Issue Sort Value:: 2021-0156-0001-0000
Page Start:: S37
Page End:: S38
Publication Date:: 2021-06
Subjects:: Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424
Journal URLs:: http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0169-5002(21)00289-0 ↗
Languages:: English
ISSNs:: 0169-5002
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 18358.xml